# US 2018/0023108 A1 · Novel use

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2018/0023108 A1
- Document ID: US20180023108A1
- Status: Published application
- Kind: A1
- Application number: 15/549,602
- Filed: 2016-02-10
- Published: 2018-01-25
- Earliest claimed: 2015-02-10
- Assignees: Nuclera Nucleics Ltd.
- Applicants: Nuclera Nucleics Ltd.
- Inventors: Michael C. CHEN; Radu A. LAZAR; Jiahao HUANG; Gordon R. MCINROY
- Web page: https://patentgrep.com/patent/US20180023108A1

## CPC

- C12P 19/34: Polynucleotides, e.g. nucleic acids, oligoribonucleotides
- C12N 9/12: transferring phosphorus containing groups, e.g. kinases (2.7)
- C12Q 1/68: involving nucleic acids
- C12Y 207/07031: DNA nucleotidylexotransferase (2.7.7.31), i.e. terminal deoxynucleotidyl transferase
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Y: ENZYMES

## Abstract

The invention relates to the use of specific terminal deoxynucleotidyl transferase (TdT) enzymes in a method of nucleic acid synthesis, to methods of synthesizing nucleic acids, and to the use of kits comprising said enzymes in a method of nucleic acid synthesis. The invention also relates to the use of terminal deoxynucleotidyl transferases and 3′-blocked nucleotide triphosphates in a method of template independent nucleic acid synthesis.

## Claims

### Claim 1

A method of nucleic acid synthesis comprising a step of providing a terminal deoxynucleotidyl transferase (TdT) enzyme comprising an amino acid sequence having at least 95% sequence identity to any one of SEQ ID NOs: 1 to 5 and 8, such as any of SEQ ID NOs: 1, 2, or 8.

### Claim 2

(canceled)

### Claim 3 (depends on 1)

A method of nucleic acid synthesis, comprising steps of:
(a) providing an initiator sequence;
(b) adding a 3′-blocked nucleotide triphosphate to said initiator sequence in the presence of a terminal deoxynucleotidyl transferase (TdT) as defined in claim 1;
(c) removal of all reagents from the initiator sequence;
(d) cleaving the blocking group from the 3′-blocked nucleotide triphosphate in the presence of a cleaving agent; and
(e) removal of the cleaving agent.

### Claim 4 (depends on 3)

The method as defined in claim 3, wherein greater than 1 nucleotide is added by repeating steps (b) to (e).

### Claim 5 (depends on 3)

The method as defined in claim 3, wherein the 3′-blocked nucleotide triphosphate is blocked by either a 3′-O-azidomethyl, 3′-aminoxy or 3′-O-allyl group.

### Claim 6 (depends on 3)

The method as defined in claim 3, wherein the terminal deoxynucleotidyl transferase (TdT) is added in the presence of an extension solution comprising one or more buffers, such as Tris or cacodylate, one or more salts; and/or inorganic pyrophosphatase, such as purified, recombinant inorganic pyrophosphatase from Saccharomyces cerevisiae.

### Claim 7 (depends on 3)

The method as defined in claim 3, wherein step (b) is performed at a pH range of between 5 and 10, step (d) is performed at a temperature of less than 99° C. and/or steps (c) and (e) are performed by applying a wash solution.

### Claim 8 (depends on 3)

The method as defined in claim 3, wherein the cleaving agent is a chemical cleaving agent such as tris(2-carboxyethyl)phosphine (TCEP), a palladium complex and sodium nitrite or the cleaving agent an enzymatic cleaving agent.

### Claim at position 9

9-10. (canceled)

### Claim 11 (depends on 3)

The method as defined in claim 3, wherein the cleaving agent is added in the presence of a cleavage solution comprising a denaturant, such as urea, guanidinium chloride, formamide, or betaine, and one or more buffers.

### Claim at position 11

12-13. (canceled)

### Claim 14 (depends on 3)

The method as defined in claim 3, wherein the method is performed within a flow instrument, such as a microfluidic or column-based flow instrument and/or is performed within a plate or microarray setup.

### Claim 15

(canceled)

### Claim 16 (depends on 3)

The method as defined in claim 3, wherein the initiator sequence is between 5 and 50 nucleotides long, such as between 10 and 30 nucleotides long, in particular approximately 20 nucleotides long and wherein the initiator sequence is immobilised on a solid support such as via a reversible interacting moiety.

### Claim at position 15

17-19. (canceled)

### Claim 20 (depends on 16)

The method as defined in claim 16, further comprising a stop of extracting the resultant nucleic acid by removing the reversible interacting moiety.

### Claim 21 (depends on 16)

The method as defined in claim 16, wherein the reversible interacting moiety is a chemically-cleavable linker, such as a disulfide, allyl or azide-masked hemiaminal ether and the method further comprises a step of extracting the resultant nucleic acid by cleaving the chemically-cleavable linker, such as by the addition of tris(2-carboxyethyl)phosphine (TCEP), dithiothreitol (DTT) or a palladium complex.

### Claim 22

(canceled)

### Claim 23 (depends on 3)

The method as defined in claim 3, wherein the initiator sequence contains at least one restriction site and the method further comprises a step of extracting the resultant nucleic acid by using a restriction enzyme and/or the initiator sequence contains at least one uridine.

### Claim at position 20

24-25. (canceled)

### Claim 26 (depends on 3)

The method as defined in claim 3, further comprising a step of amplifying the resultant nucleic acid, such as by PCR.

### Claim 27 (depends on 1)

A kit for use in the method of nucleic acid synthesis as defined in claim 1, optionally in combination with one or more components selected from: an initiator sequence, one or more 3′-blocked nucleotide triphosphates, inorganic pyrophosphatase, such as purified, recombinant inorganic pyrophosphatase from Saccharomyces cerevisiae, and a cleaving agent; further optionally together with instructions for use.

### Claim 28 (depends on 27)

The kit as defined in claim 27, which additionally comprises one or more components selected from the group: an extension solution, a wash solution and/or a cleaving solution.

### Claim 29

A method of template-independent acid synthesis comprising a step of providing a 3′-blocked nucleotide triphosphate, wherein the 3′-blocked nucleotide triphosphate is selected from a compound of formula (I), (II), (III), or (IV):
wherein
R1 represents NRaRb, wherein Ra and Rb independently represent hydrogen or C1-6 alkyl,
R2 represents hydrogen, C1-6 alkyl, C1-6 alkoxy, COH or COOH,
X represents C1-6 alkyl, NH2, N3 or —OR3,
R3 represents C1-6 alkyl, CH2N3, NH2 or allyl,
Y represents hydrogen, halogen or hydroxyl, and
Z represents CR4 or N, wherein R4 represents hydrogen, C1-6 alkyl, C1-6 alkoxy, COH or COOH.

### Claim at position 25

30-34. (canceled)

### Claim 35 (depends on 29)

The method as defined in claim 29, wherein the 3′-blocked nucleotide triphosphate is selected from deoxyadenosine triphosphate deoxyguanosine triphosphate, deoxythymidine triphosphate, deoxycytidine triphosphate, 2′-deoxy-uridine triphosphate, 5-aza-2′-deoxy-cytidine-triphosphate, 5-hydroxymethyl-deoxycytidine triphosphate, 5-carboxy-deoxycytidine triphosphate, 5-formyl-deoxycytidine triphosphate, n6-methyladenosine triphosphate, and 5-hydroxymethyl-deoxy-uridine triphosphate.

### Claim 36

A method of nucleic acid synthesis comprising a step of providing an inorganic pyrophosphatase such as purified, recombinant inorganic pyrophosphatase from Saccharomyces cerevisiae.

### Claim 37

(canceled)

### Claim 38 (depends on 3)

A kit for use in the method of nucleic acid synthesis as defined in claim 3, optionally in combination with one or more components selected from: an initiator sequence, one or more 3′-blocked nucleotide triphosphates, inorganic pyrophosphatase, such as purified, recombinant inorganic pyrophosphatase from Saccharomyces cerevisiae, and a cleaving agent; further optionally together with instructions for use.
